MYC and chronic myelogenous leukemia, BCR-ABL1 positive: Imatinib-resistant clones KCL-22R displayed persistently high expression of MYC, while overexpression of BCL-2 was additionally found in CML-T1R clones (Supplementary Results; Supplementary Figures S14–S17).